Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients

Table 1

Patient demographics.

Gender	Male 7, female 5
Mean age	14 ± 2 years
	CsA/MMF: 𝑛=1
Immunosuppressant before switch	TAC/MMF: 𝑛=10
	pANCA-positive vasculitis: 𝑛=2
	Renal dysplasia: 𝑛=5
Underlying disease	Nephronophthisis: 𝑛=2
	Obstructive uropathy: 𝑛=1
	Congenital nephrotic syndrome: 𝑛=1
Living donation/cadaveric donation	4/7
Mean time from transplantation to switch	4.4 ± 2.6 years